Massachusetts Financial Services’s Agilon Health AGL Stock Holding History

Massachusetts Financial Services’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.6M	Buy	+14,914	New	+$977K	﹤0.01%	849

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

SSA

Sierra Summit Advisors Incline Village, Nevada $895M AUM 106% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Belvedere Trading Chicago, Illinois $87.6B AUM 131.08% 1-Year Est. Return

CCIA

Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

IMC Chicago Chicago, Illinois $419B AUM 72.04% 1-Year Est. Return

Massachusetts Financial Services's AGL Position: Q2 2026 in Review

Massachusetts Financial Services opened a new position in Agilon Health (AGL) in Q2 2026: 14,914 shares worth $1.6M. The stake represents ﹤0.01% of the portfolio and ranks #849 among its holdings.

43 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

Massachusetts Financial Services held 14,914 shares of Agilon Health worth $1.6M as of Q2 2026.
Agilon Health was a new Massachusetts Financial Services position in Q2 2026.
Agilon Health made up ﹤0.01% of Massachusetts Financial Services's portfolio in Q2 2026, its #849 holding.
43 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.